Marietta, MA, United States of America

Michael J Reed

USPTO Granted Patents = 5 

Average Co-Inventor Count = 10.7

ph-index = 4

Forward Citations = 286(Granted Patents)


Location History:

  • Oak Ridge, TN (US) (1998)
  • Marietta, GA (US) (1998 - 2001)
  • Marietta, MA (US) (2010)

Company Filing History:


Years Active: 1998-2010

Loading Chart...
5 patents (USPTO):Explore Patents

Title: **The Innovations of Michael J Reed in Amyloid Modulation**

Introduction

Michael J Reed, an accomplished inventor based in Marietta, Massachusetts, has made significant contributions to the field of biomedical science. With a total of five patents to his name, Reed specializes in the modulation of amyloid aggregation, a crucial area of research with implications for various neurodegenerative diseases.

Latest Patents

Among his notable inventions, Reed's latest patents focus on compounds that modulate the aggregation of amyloidogenic proteins and peptides. These modulators can either promote or, more preferably, inhibit the natural aggregation of amyloids. An important aspect of his work involves the modulation of natural β-amyloid peptides (β-AP). His patented compounds consist of an Aβ aggregation core domain coupled with a modifying group, which alters the aggregation processes and inhibits neurotoxicity when in contact with these peptides. Furthermore, these modulators show efficacy in altering β-AP aggregation, particularly when there is a molar excess of the peptides relative to the modulators. Reed's patents also encompass pharmaceutical compositions and innovative diagnostic and treatment methods tailored for amyloidogenic diseases.

Career Highlights

Michael J Reed currently works at Praecis Pharmaceuticals, Inc., a company renowned for its focus on innovative therapeutic solutions. His career in pharmaceutical research reflects his dedication to solving complex health challenges through innovative chemical compounds.

Collaborations

Throughout his career, Reed has collaborated with esteemed colleagues, including Mark A Findeis and Howard Benjamin. These collaborations have played a vital role in advancing his research and patent developments, showcasing the power of teamwork in scientific innovation.

Conclusion

Michael J Reed stands out as a prominent inventor with a focus on amyloid modulation. His groundbreaking patents not only reflect his expertise but also underscore the potential for impactful treatments for neurodegenerative diseases. As the field progresses, Reed's contributions may lead to significant advancements in understanding and treating conditions associated with amyloid aggregation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…